THE Therapeutic Goods Administration (TGA) has advised that supply shortages of Etopophos etoposide 1 g (as phosphate) and Etopophos etoposide phosphate 113.6 mg (equivalent to 100 mg etoposide) powder for injection vials are expected to continue until 01 Aug 2017.
Previously, health professionals were advised that supply would resume next month.
The TGA advises that the alternative product Etoposide 100 mg/5 mL is available.
For more info contact the TGA on medicine.shortages@tga.gov.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 20 Mar 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 20 Mar 17